Duration of Antidepressant Treatment for Patients with a History of Depression
For patients with a history of depression, antidepressant treatment should be continued for at least 4-9 months after achieving remission for a first episode, and for 2 years or longer for patients with recurrent depression (two or more episodes). 1
Treatment Duration Based on Episode History
The recommended duration of antidepressant treatment varies depending on the patient's depression history:
First episode of depression:
Recurrent depression (2+ episodes):
Persistent Depressive Disorder:
- Typically requires longer treatment duration due to its chronic nature 1
Phases of Antidepressant Treatment
The American College of Physicians defines three distinct treatment phases 1:
Acute Phase (6-12 weeks):
- Goal: Achieve initial response and symptom reduction
- Regular monitoring should begin within 1-2 weeks of starting treatment 2
Continuation Phase (4-9 months):
- Goal: Prevent relapse of the same depressive episode
- Approximately 30-50% of patients will relapse if medication is discontinued during this phase, compared to only 10-15% if continued 3
Maintenance Phase (≥1 year or longer):
- Goal: Prevent recurrence of new episodes
- Essential for patients with multiple previous episodes
Monitoring and Assessment
- Assess patient status, therapeutic response, and adverse effects beginning within 1-2 weeks of starting therapy 2
- Follow-up at 4 weeks, then every 3 months if stable 1
- Early follow-up is crucial as suicide risk is highest during the first 3-7 days after medication initiation 1
- If inadequate response occurs within 6-8 weeks of starting therapy, treatment modification is recommended 2, 1
Risk Factors for Relapse Requiring Longer Treatment
Patients with the following factors may benefit from extended treatment durations 1:
- Multiple previous episodes of depression
- Severe depressive symptoms
- Comorbid medical or psychiatric conditions
- Residual symptoms after acute treatment
Common Pitfalls to Avoid
Premature discontinuation: Early discontinuation is widespread in community treatment, especially among socioeconomically disadvantaged patients, with studies showing that 42.4% of patients discontinue within the first 30 days 4
Inadequate dose: Treatment failure is often due to subtherapeutic dosing in general practice 5
Confusing withdrawal symptoms with relapse: Withdrawal symptoms (such as low mood, dizziness) may be misinterpreted as depression relapse when discontinuing antidepressants 6
Lack of psychotherapy: Patients receiving psychotherapy in addition to medication are significantly more likely to continue antidepressant treatment beyond 30 days (68.0% versus 43.7%) 4
When discontinuation is appropriate, a gradual tapering approach is generally recommended, although evidence suggests that even with tapering, discontinuation may lead to higher risk of relapse compared to continuation of antidepressants 6.